Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Claxton

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 5, 2024
Social Decision-Making Analysis: A General Approach to Inform Decisions on Resources in the Public SectorFrancesco Longo, Karl Claxton, Susan Griffin, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 30, 2010
Eliciting distributions to populate decision analytic modelsLaura Bojke, Karl Claxton, Yolanda Bravo-Vergel, et al.
Nature|July 10, 2015
Policy: Development goals should enable decision-makingKeith Shepherd, Douglas Hubbard, Norman Fenton, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 24, 2011
A framework for addressing structural uncertainty in decision modelsChristopher H Jackson, Laura Bojke, Simon G Thompson, et al.
Statistics in Medicine|July 13, 2011
Methods to elicit experts' beliefs over uncertain quantities: application to a cost effectiveness transition model of negative pressure wound therapy for severe pressure ulcerationMarta O Soares, Laura Bojke, Jo Dumville, et al.
Applied Health Economics and Health Policy|March 22, 2026
Insights from Financial Economics to Value Healthcare Investments that Reduce System-Level Risks: Example of Disease Elimination and EradicationMegha Rao, Mark Freeman, Jacco Thijssen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 28, 2015
Unifying Research and Reimbursement Decisions: Case Studies Demonstrating the Sequence of Assessment and Judgments RequiredClaire McKenna, Marta Soares, Karl Claxton, et al.
Journal of Health Services Research & Policy|February 9, 2013
Understanding Harris' understanding of CEA: is cost effective resource allocation undone?Richard Edlin, Christopher McCabe, Jeff Round, et al.
Journal of Benefit-Cost Analysis|December 7, 2020
Accounting for Timing when Assessing Health-Related PoliciesKarl Claxton, Miqdad Asaria, Collins Chansa, et al.
Pharmacoeconomics|January 19, 2013
When does NICE recommend the use of health technologies within a programme of evidence development? : a systematic review of NICE guidanceLouise Longworth, Jihee Youn, Laura Bojke, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 5, 2024
Social Decision-Making Analysis: A General Approach to Inform Decisions on Resources in the Public SectorFrancesco Longo, Karl Claxton, Susan Griffin, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 30, 2010
Eliciting distributions to populate decision analytic modelsLaura Bojke, Karl Claxton, Yolanda Bravo-Vergel, et al.
Nature|July 10, 2015
Policy: Development goals should enable decision-makingKeith Shepherd, Douglas Hubbard, Norman Fenton, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 24, 2011
A framework for addressing structural uncertainty in decision modelsChristopher H Jackson, Laura Bojke, Simon G Thompson, et al.
Statistics in Medicine|July 13, 2011
Methods to elicit experts' beliefs over uncertain quantities: application to a cost effectiveness transition model of negative pressure wound therapy for severe pressure ulcerationMarta O Soares, Laura Bojke, Jo Dumville, et al.
Applied Health Economics and Health Policy|March 22, 2026
Insights from Financial Economics to Value Healthcare Investments that Reduce System-Level Risks: Example of Disease Elimination and EradicationMegha Rao, Mark Freeman, Jacco Thijssen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 28, 2015
Unifying Research and Reimbursement Decisions: Case Studies Demonstrating the Sequence of Assessment and Judgments RequiredClaire McKenna, Marta Soares, Karl Claxton, et al.
Journal of Health Services Research & Policy|February 9, 2013
Understanding Harris' understanding of CEA: is cost effective resource allocation undone?Richard Edlin, Christopher McCabe, Jeff Round, et al.
Journal of Benefit-Cost Analysis|December 7, 2020
Accounting for Timing when Assessing Health-Related PoliciesKarl Claxton, Miqdad Asaria, Collins Chansa, et al.
Pharmacoeconomics|January 19, 2013
When does NICE recommend the use of health technologies within a programme of evidence development? : a systematic review of NICE guidanceLouise Longworth, Jihee Youn, Laura Bojke, et al.
Pageof 12